PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32845528-0	2021	Sclerostin-Neutralizing Antibody Treatment Rescues Negative Effects of Rosiglitazone on Mouse Bone Parameters.	Rosiglitazone	71-84	sclerostin	Mus musculus	0-10	
32845528-13	2021	These data suggest targeting sclerostin can prevent rosiglitazone-induced bone loss and reduce BM adiposity, in some, but not all BMAT locations.	Rosiglitazone	52-65	sclerostin	Mus musculus	29-39